copia de analytical information 30 sep 2010

Upload: ivan-aguilar-cabrera

Post on 07-Apr-2018

217 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/6/2019 Copia de Analytical Information 30 Sep 2010

    1/12

    CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

    2008

    (USD in thousands except earnings per share) Q1 Q2 Q3 Q4 TOTAL

    Continuing operations:

    Revenues 31,523 37,077 44,984 27,121 140,705

    Cost of sales (26,822) (24,190) (33,586) (25,764) (110,362

    Gross profit 4,701 12,887 11,398 1,357 30,343

    Net adjustment from change in fair value of biological assets 1,644 (867) (1,050) 17,349 17,076

    Profit after adjusment from biological assets 6,345 12,020 10,348 18,706 47,419

    Administrative expenses (3,469) (3,380) (2,200) (3,610) (12,659

    Selling expenses (3,391) (3,886) (4,944) (4,065) (16,286

    Other income 273 1,144 28 (712) 733

    Other expenses (538) (1,640) 373 (3,001) (4,806

    Operating profit (780) 4,258 3,605 7,318 14,401

    Share of gain (loss) of associated companies - 67 - (146) (79

    Financial income 1,739 124 314 (202) 1,975

    Financial costs (3,283) (2,051) (2,888) (3,152) (11,374Change in fair value of derivative financial instruments 5,810 (5,485) (7,211) 6,886 -

    Currency translation differences 1,425 (1,270) (3,699) (498) (4,042

    Profit (loss) before income tax 4,911 (4,357) (9,879) 10,206 881

    Income tax (808) 649 1,654 (1,391) 104

    Profit (loss) for the period from continuing operations 4,103 (3,708) (8,225) 8,815 985

    Discontinued operations:

    Loss for the period from discotinued operations - - - - -

    Profit (loss) for the period 4,103 (3,708) (8,225) 8,815 985

    Depreciation & Amortization 1,280 2,674 682 1,682 6,318

    Workers Profit Sharing 727 (609) (1,226) 915 (193

    Amortization without IAS-41 377 418 538 490 1,823Stock options - 239 256 66 561

    EBITDA A.F.V.A. 1,492 7,058 2,916 13,694 25,160

    EBITDA B.F.V.A. 225 8,343 4,504 (3,165) 9,907

    Net profit (loss) attributable to:

    Non-controlling interests - - - - -

    Equity holders of Camposol Holding PLC 4,103 (3,708) (8,225) 8,815 985

    Earnings per share in USD

    From continuing operations:

    Basic 0.147 (0.131) (0.287) 0.302 0.034

    Diluted 0.147 (0.131) (0.287) 0.302 0.034

    From discontinued operations:

    Basic - - - - -

    Diluted - - - - -

    From total operations:

    Basic 0.147 (0.131) (0.287) 0.302 0.034

    Diluted 0.147 (0.131) (0.287) 0.302 0.034

    Average outstanding shares in millions*)

    For Basic calculation

    Outstanding shares*) during the quarter. 27,925,070 28,212,690 28,693,799 29,174,909 29,174,909

    Outstanding shares*) year to date. 27,925,070 29,833,820 29,833,820 29,833,820 29,833,820

    For Diluted calculation

    Outstanding shares*) during the quarter. 27,925,070 28,212,690 28,693,799 29,174,909 29,174,909

    Outstanding shares*) year to date. 27,925,070 29,833,820 29,833,820 29,833,820 29,833,820*) Weighted average number of ordinary outstanding shares.

    Number of ordinary shares at end of period 27,925,070 29,833,820 29,833,820 29,833,820 29,833,820

  • 8/6/2019 Copia de Analytical Information 30 Sep 2010

    2/12

    CAMPOSOL HOLDING PLC

    CONSOLIDATED STATEMENT OF FINANCIAL POSITION

    2008

    (USD in thousands) 31 Mar 30 Jun 30 Sep 31 Dec 31 Mar

    Assets

    Non-current assets

    Property, plant and equipment, net 106,075 107,509 115,324 120,360 119,917

    Investments in associated companies 417 421 420 274 274Intangibles 27,140 28,611 29,117 27,580 27,268

    Non-current portion of biological assets 84,406 84,846 86,833 99,962 108,154

    Other accounts receivable 5,012 - - - -

    Total non-current assets 223,050 221,387 231,694 248,176 255,613

    Current assets

    Prepaid expenses 2,408 2,516 1,821 1,339 1,211

    Current portion of biological assets 10,177 11,025 4,666 15,386 13,161

    Inventories 41,609 52,423 64,269 58,037 46,473

    Other accounts receivable 10,980 16,740 18,233 14,077 16,221

    Trade accounts receivable 31,870 35,892 36,722 25,822 22,160

    Cash and cash equivalents 24,176 27,262 21,094 5,770 5,215

    Total current assets 121,220 145,858 146,805 120,431 104,441Total assets 344,270 367,245 378,499 368,607 360,054

    Equity and liabilities

    Capital and reserve attributable to

    shareholders of the Company

    Capital stock 25,895 507 507 507 507

    Share premium 179,525 228,991 229,266 212,318 212,318

    Share Warrants - - - 4,114 4,114

    Share options - 239 495 745 745

    Cash flow hedge - - - (11,093) (8,970)

    Retained earnings 17,288 369 (7,099) 14,545 14,476

    222,708 230,106 223,169 221,136 223,190

    Minority interests 88 88 88 88 88

    Total equity 222,796 230,194 223,257 221,224 223,278

    Non-current liabilities

    Long-term debt 65,388 69,675 66,853 56,826 52,553

    Deferred income tax 17,423 13,112 10,933 10,094 10,467

    Other payables 581 4,908 15,865 19,707 17,256

    83,392 87,695 93,651 86,627 80,276

    Current liabilities

    Accounts payable to related companies 346 - - 8 -

    Current portion of long-term debt 5,481 4,621 6,634 9,528 13,382

    Trade payables 22,842 21,485 28,412 25,126 18,735

    Other payables 9,411 8,372 11,795 9,638 8,449

    Bank loans 2 14,878 14,750 16,456 15,93438,082 49,356 61,591 60,756 56,500

    Total liabilities 121,474 137,051 155,242 147,383 136,776

    Total equity and liabilities 344,270 367,245 378,499 368,607 360,054

  • 8/6/2019 Copia de Analytical Information 30 Sep 2010

    3/12

    2009 2010

    30 Jun 30 Sep 31 Dec 31 Mar 30 Jun 30 Sep 31 Dec

    118,775 116,583 111,927 110,329 108,896 115,526

    574 266 422 601 600 38626,962 26,637 26,586 26,583 26,490 27,303

    110,899 116,629 125,802 133,087 137,223 143,120

    - - - - - -

    257,210 260,115 264,737 270,600 273,209 286,335 -

    825 579 643 819 544 543

    8,462 7,817 15,031 10,324 9,216 10,420

    37,022 34,103 32,033 31,583 27,977 29,333

    17,430 14,410 12,445 12,409 15,120 12,493

    24,818 19,295 20,589 14,809 14,201 12,803

    1,191 2,255 5,696 5,322 10,545 13,236

    89,748 78,459 86,437 75,266 77,603 78,828 -346,958 338,574 351,174 345,866 350,812 365,163 -

    507 507 507 507 507 507

    212,318 212,318 212,318 212,318 212,318 212,318

    4,114 4,114 2,050 2,050 2,050 2,050

    819 1,062 914 959 991 1,026

    (3,854) (574) - - - -

    10,646 11,253 18,628 16,704 11,396 19,265

    224,550 228,680 234,417 232,538 227,262 235,166 -

    88 88 88 88 88 516

    224,638 228,768 234,505 232,626 227,350 235,682 -

    48,355 44,105 48,319 43,890 60,449 62,224

    10,044 10,349 13,414 13,256 14,053 13,786

    11,455 8,432 10,140 10,144 10,740 10,640

    69,854 62,886 71,873 67,290 85,242 86,650 -

    94 - -

    15,560 17,293 8,635 11,728 3,193 3,991

    16,797 13,726 20,262 18,137 16,500 21,367

    6,784 6,954 6,614 5,419 6,555 6,973

    13,231 8,947 9,285 10,666 11,972 10,50052,466 46,920 44,796 45,950 38,220 42,831 -

    122,320 109,806 116,669 113,240 123,462 129,481 -

    346,958 338,574 351,174 345,866 350,812 365,163 -

  • 8/6/2019 Copia de Analytical Information 30 Sep 2010

    4/12

    CAMPOSOL HOLDING PLC

    CONSOLIDATED STATEMENT OF CASH FLOWS

    2008

    (USD in thousands) 1Q 2Q 3Q 4Q

    Cash flow from operating activities

    Collections 43,022 31,739 45,470 38,021Payment to suppliers and employees (46,503) (33,425) (49,433) (44,947)

    Interest paid (2,904) (2,386) (2,869) (3,133)

    Other collections 10,190 (12,883) 6,315 5,152

    Income tax paid (565) (255) (17) (1,292)

    Net cash provided by (used in) operating activities 3,240 (17,210) (534) (6,199)

    Cash flow from investing activities

    Purchases of property, plant and equipment (13,035) (3,254) (10,776) (2,649)

    Purchases of intangibles (208) (501) (605) (432)

    Proceeds from sale of property, plant and equipment - - 140

    Interest received on bank deposits - - 1,416

    Payments of permanent plantations - 951 (951)Other assets 109 - (109)

    Net cash (used in) provided by investing activities (13,243) (3,646) (10,430) (2,585)

    Cash flow from financial activities

    Bank loans and overdrafts (1,476) 14,876 (128) 1,706

    Repayment of borrowings (63,267) (2,573) 65,840 (7,000)

    Payment to Camposol AS shareholders - - (320)

    Debt termination fee - - - -

    Capital contribution, net of transaction cost 9,156 11,639 650 (442)

    Capital reduction - (320) 320

    Proceeds from related companies - (597) 597

    Proceeds from long-term debt, net - (60,649) (1,401)

    Net cash (used in) provided by financial activities (55,587) 23,942 4,796 (6,540)

    Net (decrease) increase in cash and cash equivalents during the period (65,590) 3,086 (6,168) (15,324)

    Cash and cash equivalents at beginning of period 89,766 24,176 27,262 21,094

    Cash and cash equivalents at end of period 24,176 27,262 21,094 5,770

    - - - -

    Conciliation

    Operating activities:

    Profit before income tax 4,911 (4,357) (9,879) 10,206

    More (less) adjustments to profit net:Depreciation 1,219 2,181 332 1,378

    Amortization 277 277 351 303

    Provision for doubtful accounts receivable - - 3,435

    Provision for obsolescence of inventories - - -

    Write down of inventories - - -

    Biological assets (7,895) (1,289) 4,372 (12,264)

    Adjustment of retain earnings 2,123 (2,123) - -

    Fixed assets adjustement - 2,556 (2,556)

    Adjustment of intangibles - - -

    Goodwill adjustment - (1,666) 1,666

    Income tax expense - (1,511) 508 1,003

  • 8/6/2019 Copia de Analytical Information 30 Sep 2010

    5/12

    Embedded derivative 379 (335) 19 (425)

    Net cost of fixed assets sold - 552 426 (922)

    Interest expenses - - (1,416)

    Change in derivative financial instrument (6,746) 6,421 7,211 (5,275)

    Investment recovery - (67) - 67

    Income tax and workers' profit sharing 412 438 (2,179) 948

    Stock options expense - 239 256 66

    Loss of investments in associates - - 79

    Write-off of accounts receivables - - (1,315)Translation adjustment - 136 1,796 (1,501)

    Increase (decrease) on the operations flow for net variations

    Account payables to related companies (251) (346) 597 -

    Trade receivables 11,499 (5,338) 486 9,175

    Other receivables 7,004 (12,671) 5,418 3,761

    Inventories (4,327) (9,809) (14,145) (3,053)

    Prepaid expenses (601) 96 677 1,015

    Trade payables 5,329 (1,357) 6,927 (3,286)

    Other payables (10,093) 11,653 (4,597) (7,288)

    Net cash provided by (used in) operating activities 3,240 (17,210) (534) (6,199)

    - - - -

  • 8/6/2019 Copia de Analytical Information 30 Sep 2010

    6/12

    2009 2010

    TOTAL Q1 Q2 Q3 Q4 TOTAL 1Q 2Q 3Q 4Q

    158,252 36,572 28,552 31,523 31,416 128,063 31,611 27,944 31,823(174,308) (34,515) (26,166) (25,801) (27,887) (114,369) (30,773) (28,191) (33,172)

    (11,292) (2,770) (2,606) (2,465) (2,438) (10,279) (2,485) (1,999) (2,357)

    8,774 1,660 2,116 5,759 3,804 13,339 2,253 4,039 4,286

    (2,129) 496 (806) (193) (538) (1,041) (214) (201) (194)

    (20,703) 1,443 1,090 8,823 4,357 15,713 392 1,592 386 -

    (29,714) (1,049) (434) (1,054) (1,337) (3,874) (697) (712) (4,971)

    (1,746) (29) (35) (18) (126) (208) (114) (176) (101)

    140 16 77 111 4,282 4,486 - 5,147

    1,416 5 1 3 (9) - - -

    - - - - - - -- - - - - - -

    (29,904) (1,057) (391) (958) 2,810 404 (811) (888) 75 -

    14,978 (522) (2,703) (4,284) 718 (6,791) 1,381 1,306 (1,472)

    (7,000) - - - - - -

    (320) - - - - - -

    - - - - - (3,682) -

    21,003 - - - - - -

    - - - - - - -

    - - - - - - -

    (62,050) (419) (2,020) (2,517) (4,444) (9,400) (1,336) 6,895 3,702

    (33,389) (941) (4,723) (6,801) (3,726) (16,191) 45 4,519 2,230

    (83,996) (555) (4,024) 1,064 3,441 (74) (374) 5,223 2,691

    89,766 5,770 5,215 1,191 2,255 5,770 5,696 5,322 10,545

    5,770 5,215 1,191 2,255 5,696 5,696 5,322 10,545 13,236

    - - - - - - - - -

    - -

    881 (42) (4,980) 290 8,144 3,412 (2,078) (4,512) 7,601 -

    5,110 1,511 1,506 1,495 1,656 6,168 1,569 1,602 1,563

    1,208 341 341 343 177 1,202 117 273 194

    3,435 - 86 2,542 2,628 - 170 (8)

    - - - 2,500 2,500 126 315 410

    - - - 1,493 1,493 - (628) (776)

    (17,076) (5,968) 1,955 (5,086) (16,386) (25,485) (2,578) (3,028) (7,101)

    - - - - - - -

    - - - - - - -

    - - - - - - 211

    - - - - - - -

    - - - - - - -

  • 8/6/2019 Copia de Analytical Information 30 Sep 2010

    7/12

    (362) 371 370 - (741) - - -

    56 6 49 (195) 433 293 22 (955) (1,640)

    (1,416) (5) (1) (3) 10,636 10,627 2,322 7,968 1,759

    1,611 (308) (743) (477) (83) (1,611) - -

    - - - - - - -

    (381) 494 (2,774) (360) 6,282 3,642 (82) 1,321 (367)

    561 74 243 (61) 256 45 32 35

    79 (300) 308 (156) (148) (178) - 214

    (1,315) - - - - - -431 (29) 9 (11) (50) (81) 83 (134) 80

    - - - - - -

    15,822 3,662 (2,658) 5,496 (3,838) 2,662 5,780 573 1,382

    3,512 (2,144) (1,209) 4,068 865 1,580 36 732 (144)

    (31,334) 11,564 9,451 2,919 (429) 23,505 323 3,919 (990)

    1,187 (242) 15 246 677 696 (176) 275 -

    7,613 (7,726) (1,938) (3,071) 7,863 (4,872) (2,124) (1,672) 4,901

    (10,325) (42) 1,923 2,532 (17,167) (12,754) (2,815) (4,659) (6,938)

    (20,703) 1,443 1,090 8,823 4,357 15,713 392 1,592 386

    - - - - - - - - - -

  • 8/6/2019 Copia de Analytical Information 30 Sep 2010

    8/12

    TOTAL

    91,378(92,136)

    (6,841)

    10,578

    (609)

    2,370

    (6,380)

    (391)

    5,147

    -

    --

    (1,624)

    1,215

    -

    -

    (3,682)

    -

    -

    -

    9,261

    6,794

    7,540

    5,696

    13,236

    13,236

    1,011

    4,734

    584

    162

    851

    (1,404)

    (12,707)

    -

    -

    211

    -

    -

  • 8/6/2019 Copia de Analytical Information 30 Sep 2010

    9/12

    -

    (2,573)

    12,049

    -

    -

    872

    112

    36

    -29

    -

    7,735

    624

    3,252

    99

    1,105

    (14,412)

    2,370

    -

  • 8/6/2019 Copia de Analytical Information 30 Sep 2010

    10/12

    CAMPOSOL HOLDING PLC

    SEGMENT INFORMATION

    2008

    (USD in thousands) sparagusAvocado Artichoke Pepper Mango Shrimp Other

    Revenues 62,073 31,611 16,963 13,255 8,621 5,367 2,815

    Cost of goods sold (55,474) (11,111) (15,964) (12,724) (6,760) (4,596) (3,733)

    Gross profit 6,599 20,500 999 531 1,861 771 (918)

    Volumes produced (net MT) 21,893 19,784 3,585 7,450 8,641 536 -

    Volumes sold (net MT) 17,877 19,734 4,771 6,890 8,783 748 -

    Weighted Average prices (US$ /Kg.) 3.47 1.60 3.56 1.92 0.98 7.18 -

  • 8/6/2019 Copia de Analytical Information 30 Sep 2010

    11/12

  • 8/6/2019 Copia de Analytical Information 30 Sep 2010

    12/12

    As of 30 Sep 2010

    Avocado Artichoke Pepper Mango Grapes Shrimp Other TOTAL

    19,718 45 7,818 12,980 384 3,494 3,163 83,481

    (7,493) (72) (5,278) (7,027) (193) (3,216) (4,129) (56,181)

    12,225 (27) 2,540 5,953 191 278 (966) 27,300

    12,032 - 1,931 9,461 85 467 - 34,635

    12,050 16 3,078 9,910 210 479 - 37,662

    1.64 2.81 2.54 1.31 1.83 7.29 -